Form 4: Ikena Oncology Executive Sells Shares
Insider Transaction (Form 4)
Robert B Lally, Principal Accounting Officer of Ikena Oncology, Inc., sold 3,196 shares of common stock on July 16, 2026.
Summary
- Open-market sale: disposed of 1,671 Common Stock at $5.50 ($9,190) on July 16, 2026; holds 57,107 after (Direct).
- Open-market sale: disposed of 1,525 Common Stock at $5.34 ($8,144) on July 17, 2026; holds 55,582 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $17,334 of stock on the open market.
Insider Transactions
Robert B Lally — Officer (Principal Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Open-market sale | Common Stock | 1,671 | $6 | $9.2K | 57,107 |
| 2026-07-17 | Open-market sale | Common Stock | 1,525 | $5 | $8.1K | 55,582 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Open-market sale (1,671 shares) |
| 2026-07-17 | Open-market sale (1,525 shares) |
Keywords
insider transaction, Form 4, IMA, ImageneBio, Inc., bearish, Robert B Lally
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.